Our organic revenue growth of 7% and our 2% EBITDA growth shows how aggressively we manage costs and implemented price increases to offset as much of that FX headwind as possible.
We reported $4.64 billion in revenue, which reflects a 1% increase on a reported basis and a 7% organic growth rate.
Guidance for Q1 implies year-over-year sales contraction of 7% at the midpoint on a reported basis and 5% organically.
Revenue is expected to benefit from 7% volume growth with the largest growth in Asia and a 2% contribution from higher prices.
2021 revenue is forecasted to be in the range of $4.9 to $5.1 billion, an increase of 8% at the midpoint versus 2020%, and 9% organic growth.
We reported $1.15 billion in fourth-quarter revenue, which reflects a 4% decrease on a reported basis and 2% organic growth.
FMC full-year 2020 earnings are now expected to be in the range of $6.65 to $7.35 per diluted share, a year-over-year increase of 13% at the midpoint. Adjusted earnings were $1.42 per diluted share in the quarter, a decrease of 19% versus Q4 2019.
We anticipate full year 2021 free cash flow to be in the range of $530 to $620 million, an increase of 6% at the midpoint, with free cash flow conversion 63% at the midpoint.
We are planning to repurchase between $400 and $500 million worth of FMC shares in the year with purchases in every quarter of the year, though more heavily weighted to the second half.
